{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:13:07Z","timestamp":1793729587021,"version":"4.6.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,12]],"date-time":"2020-12-12T00:00:00Z","timestamp":1607731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["fertstertreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["F&amp;S Reports"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.xfre.2020.12.002","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T09:13:04Z","timestamp":1608109984000},"page":"30-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["In\u00a0vitro fertilization cycles stimulated with follitropin delta result in similar embryo development and quality when compared with cycles stimulated with follitropin alfa or follitropin beta"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6543-8922","authenticated-orcid":false,"given":"Olga","family":"Haakman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1985-8309","authenticated-orcid":false,"given":"Tina","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelos","family":"Vilos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Vilos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlee","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9601-7098","authenticated-orcid":false,"given":"Basim","family":"Abu-Rafea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xfre.2020.12.002_bib1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.fertnstert.2016.10.033","article-title":"Individualized versus conventional ovarian stimulation for in\u00a0vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial","volume":"107","author":"Andersen","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2020.12.002_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph13070136","article-title":"Human recombinant FSH and its biosimilars: clinical efficacy, safety, and cost-effectiveness in controlled ovarian stimulation for in\u00a0vitro fertilization","volume":"13","author":"Bergandi","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.xfre.2020.12.002_bib3","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.fertnstert.2014.08.013","article-title":"Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimullerian hormone-stratified, dose-response trial in women undergoing in\u00a0vitro fertilization\/intracytoplasmic sperm injection","volume":"102","author":"Arce","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2020.12.002_bib4","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/jcph.328","article-title":"Different pharmacokinetic and pharmacodynamic properties of recombinant follicle-stimulating hormone (rFSH) derived from a human cell line compared with rFSH from a non-human cell line","volume":"54","author":"Olsson","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.xfre.2020.12.002_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2019.00429","article-title":"The development of gonadotropins for clinical use in the treatment of infertility","volume":"10","author":"Lunenfeld","year":"2019","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.xfre.2020.12.002_bib6","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1067\/S0002-9378(03)00728-2","article-title":"Pregnancy rates in varying age groups after in\u00a0vitro fertilization: a comparison of follitropin alfa (Gonal F) and follitropin beta (Follistim)","volume":"189","author":"Williams","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xfre.2020.12.002_bib7","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1093\/humrep\/14.11.2709","article-title":"Comparison of two recombinant follicle-stimulating hormone preparations in in-vitro fertilization: a randomized clinical study","volume":"14","author":"Tulppala","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfre.2020.12.002_bib8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/humrep\/15.2.239","article-title":"Recombinant follicle stimulating hormone in in-vitro fertilization treatment-clinical experience with follitropin alpha and follitropin beta","volume":"15","author":"Harlin","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfre.2020.12.002_bib9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0015-0282(99)00450-1","article-title":"A comparison of the efficacy and tolerability of two recombinant human follicle-stimulating hormone preparations in patients undergoing in\u00a0vitro fertilization-embryo transfer","volume":"73","author":"Brinsden","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2020.12.002_bib10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.rbmo.2018.10.012","article-title":"Follitropin delta in repeated ovarian stimulation for IVF: a controlled, assessor-blind Phase 3 safety trial","volume":"38","author":"Bosch","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.xfre.2020.12.002_bib11","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.rbmo.2018.12.032","article-title":"Individualization of the starting dose of follitropin delta reduces the overall OHSS risk and\/or the need for additional preventive interventions: cumulative data over three stimulation cycles","volume":"38","author":"Fern\u00e1ndez-S\u00e1nchez","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.xfre.2020.12.002_bib12","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/humrep\/der037","article-title":"The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting","volume":"26","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfre.2020.12.002_bib13","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/molehr\/gaw057","article-title":"Assessment of human embryo development using morphological criteria in an era of time-lapse, algorithms and \u2018OMICS\u2019: is looking good still important?","volume":"22","author":"Gardner","year":"2016","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.xfre.2020.12.002_bib14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1530\/EC-17-0067","article-title":"Comparative pharmacology of a new recombinant FSH expressed by a human cell line","volume":"6","author":"Koechling","year":"2017","journal-title":"Endocr Connect"},{"key":"10.1016\/j.xfre.2020.12.002_bib15","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.fertnstert.2014.12.114","article-title":"Comparison of antim\u00fcllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials","volume":"103","author":"Nelson","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2020.12.002_bib16","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/humupd\/dmu062","article-title":"Technical and performance characteristics of anti-M\u00fcllerian hormone and antral follicle count as biomarkers of ovarian response","volume":"21","author":"Iliodromiti","year":"2015","journal-title":"Hum Reprod Update"}],"container-title":["F&amp;S Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666334120301288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666334120301288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T21:04:27Z","timestamp":1762981467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666334120301288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2666334120301288"],"URL":"https:\/\/doi.org\/10.1016\/j.xfre.2020.12.002","relation":{},"ISSN":["2666-3341"],"issn-type":[{"value":"2666-3341","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In\u00a0vitro fertilization cycles stimulated with follitropin delta result in similar embryo development and quality when compared with cycles stimulated with follitropin alfa or follitropin beta","name":"articletitle","label":"Article Title"},{"value":"F&S Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xfre.2020.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc. on behalf of American Society for Reproductive Medicine.","name":"copyright","label":"Copyright"}]}}